Lipids

, Volume 13, Issue 12, pp 951–959 | Cite as

Plasma, apolipoprotein A-I and A-II levels in hyperlipidemia

  • Gustav Schonfeld
  • Alberta Bailey
  • Robert Steelman
Symposium: High Density Lipoproteins (HDL)-Structure, Function, Analysis, Clinical, Epidemiological and Metabolic Aspects of HDL

Abstract

Some of the component moieties of high denisty lipoproteins (HDL) were analyzed in normal subjects and in patients with hyperlipidemia. Apoproteins A-I and A-II were quantified by radioimmunoassay, HDL cholesterol and triglycerides were assessed on heparin-MnCl2 supernates of fasting plasmas. We found that HDL is enriched in triglycerides in all forms of hyperlipidemia, while the proportion of ApoA-II is unaltered and the proportion of ApoA-I is decreased. Thus, the composition of HDL is altered in hypertriglyceridemia. The molecular associations of ApoA-I and ApoA-II in plasma were also examined by assaying the apoprotein contents of plasma fractions prepared by ultracentrifugation and by gel filtration column chromatography. The ApoA-I contents of d<1.063 fraction increased in hyperlipidemia from <0.5% to ∼2%, but the ApoA-I contents of the d>1.21 fraction remained at <12% of total in plasmas with triglyceride levels <1500 mg/dl. d>1.21 ApoA-I rose to 23% in one plasma with a triglyceride level of >1700 mg/dl. On column chromatography, ApoA-I eluted with the lipoproteins and also in a fraction whose molecular weight (MW) appreared to be ∼50,000 daltons. The proportion of plasma ApoA-I which eluted in the 50,000 MW peak was positively correlated with plasma triglyceride levels, but at triglyceride levels of <1500 mg/dl, <20% of ApoA-I was in the 50,000 MW peak. Between levels of ∼2000 and 12,000 mg/dl, the percentage “50,000 M.W. ApoA-I” was 20–25%. The ApoA-II contents of d<1.063 fractions were also increased in hyperlipidemia, but >95% of ApoA-II was found in the HDL fractions in both normal and hyperlipidemic plasma both by column chromatography and ultracentrifugation. Thus, the molecular association of ApoA-I appears to be altered in hyperlipidemia.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rhoads, G.G., C.L. Gulbrandsen, and A. Kagan, N. Engl. J. Med. 294:293 (1976).PubMedCrossRefGoogle Scholar
  2. 2.
    Castelli, W.P., J.T. Doyle, T. Gordon, C.C. Hames, M.C. Hjortland, S.B. Hulley, A. Kagan, and W.J. Zukel, Circulation 55:767 (1977).PubMedGoogle Scholar
  3. 3.
    Miller, N.E., D.S. Thelle, O.H. Forde, and O.D. Mjos, Lancet 1:965 (1977).PubMedCrossRefGoogle Scholar
  4. 4.
    Glueck, C., R.W. Fallat, F. Millett, and P.M. Steiner, Arch. Intern. Med. 135:1025 (1975).PubMedCrossRefGoogle Scholar
  5. 5.
    Glueck, C.J., P.S. Gartside, P.M. Steiner, M. Miller, T. Todhunter, J. Haaf, M. Pucke, M. Terrana, R.W. Fallat, and M.L. Kashyap, Atherosclerosis 27:387 (1977).PubMedCrossRefGoogle Scholar
  6. 6.
    Stamler, J., “Preventive Cardiology,” Grune & Stratton, New York, 1967.Google Scholar
  7. 7.
    Wood, P.D., W. Haskell, H. Klein, S. Lewis, M.P. Stern, and J.W. Farquhar, Metabolism 25:1249 (1976).PubMedCrossRefGoogle Scholar
  8. 8.
    Scanu, A.M., and C. Wisdom, Annu. Rev. Biochem. 41:703 (1972).PubMedCrossRefGoogle Scholar
  9. 9.
    Schonfeld, G., and B. Pfleger, J. Clin. Invest. 54:236 (1974).PubMedGoogle Scholar
  10. 10.
    Albers, J.J., P.W. Hahl, V.G. Cabana, W.R. Hazzard, and J.J. Hoover, Metabolism 25:633 (1976).PubMedCrossRefGoogle Scholar
  11. 11.
    Karlin, J.B., D.J. Juhn, J.I. Starr, A.M. Scanu, and A.H. Rubenstein, J. Lipid Res. 17:30 (1976).PubMedGoogle Scholar
  12. 12.
    Curry, M.D., P. Alaupovic, and C.A. Suenram, Clin. Chem. 22:315 (1976).PubMedGoogle Scholar
  13. 13.
    Schonfeld, G., J. Chen, W.F. McDonnell, and I. Jeng, J. Lipid Res. 18:645 (1977).PubMedGoogle Scholar
  14. 14.
    Cheung, M.A., and J.J. Albers, J. Clin. Invest. 60:43 (1977).PubMedGoogle Scholar
  15. 15.
    Assmann, G., E. Smootz, K. Alder, A. Capurso, and K. Oette, J. Clin. Invest. 59:565 (1977).PubMedGoogle Scholar
  16. 16.
    Brunzell, J.D., J.J. Albers, L.B. Haas, A.P. Goldberg, L. Agadoa, and D.J. Sherrard, Metabolism 26:903 (1977).PubMedCrossRefGoogle Scholar
  17. 17.
    Albers, J.J., M.C. Cheung, and W.R. Hazzard, Metabolism 27:479 (1978).PubMedCrossRefGoogle Scholar
  18. 18.
    Burslem, J., G. Schonfeld, M.A. Howald, S.W. Weidman, and J.P. Miller, Metabolism 27:711 (1978).PubMedCrossRefGoogle Scholar
  19. 19.
    Mahley, R.W., and T.L. Innerarity, J. Biol. Chem. 252:3980 (1977).PubMedGoogle Scholar
  20. 20.
    Miller, N.E., D.B. Weinstein, T.E. Carew, T. Koschinsky, and D. Steinberg, J. Clin. Invest. 60:78 (1977).PubMedGoogle Scholar
  21. 21.
    Stein, O., J. Vanderhoff, and Y. Stein, Atherosclerosis 26:465 (1977).PubMedCrossRefGoogle Scholar
  22. 22.
    Beaumont, J.L., L.A. Carlson, G.R. Cooper, Z. Fejfar, D.S. Fredrickson, and T. Strasser, Bull. WHO 43:89 (1970).Google Scholar
  23. 23.
    Manual of Laboratory Operations, Lipid Research Clinics Program, Vol. 1, “Lipid and Lipoprotein Analysis”, DHEW Publ. No. (NIH) 75-628, 1974.Google Scholar
  24. 24.
    Nie, N.H., D.H. Bent, and C.H. Hull, “Statistical Package for the Social Scienes,” McGraw-Hill, St. Louis, 1970.Google Scholar
  25. 25.
    Wood, P.D.S., M.P. Stern, A. Silvers, G.M. Reaven, and J. von der Groeben, Circulation 45:114 (1972).PubMedGoogle Scholar
  26. 26.
    Freifelder, D., “Physical Biochemistry, Applications to Biochemistry and Molecular Biology,” W.A. Freeman & Co., San Francisco, 1976, pp. 189–190.Google Scholar
  27. 27.
    Lowry, O.H., N.J. Rosebrough, A.L. Farr, and R.J. Randall, J. Biol. Chem. 193:265 (1951).PubMedGoogle Scholar
  28. 28.
    Mjos, O.D., D.S. Thelle, O.H. Forde, and H. Vikrot, Acta Med. Scand. 201:323 (1977).PubMedCrossRefGoogle Scholar
  29. 29.
    Albers, J.J., G.R. Warnick, and W.R. Hazzard, Clin. Chim. Acta 75:193 (1977).PubMedCrossRefGoogle Scholar
  30. 30.
    Utermann, G., M. Jaeschke, and J. Menzel, FEBS Lett. 56:352 (1975).PubMedCrossRefGoogle Scholar
  31. 31.
    Pagnan, A., R.J. Havel, J.P. Kane, and L. Kotite, J. Lipid Res. 18:613 (1977).PubMedGoogle Scholar
  32. 32.
    Weidman, S.W., M. Raben, J.L. Witztum, and G. Schonfeld, Clin. Res. 25:568 (1977) (Abstract).Google Scholar
  33. 33.
    Schonfeld, G., R.S. Lees, P.K. George, and B. Pfleger, J. Clin. Invest. 53:1458 (1974).PubMedCrossRefGoogle Scholar
  34. 34.
    Ewing, A.M., N.K. Freeman, and F.T. Lindgren, in “Advances in Lipid Research,” Vol. 3, Edited by R. Paoletti and D. Kritchevsky, Academic Press, New York, 1965, pp. 25–60.Google Scholar
  35. 35.
    Myers, L.H., N.R. Phillips, and R.J. Havel, J. Lab. Clin. Med. 88:491 (1976).PubMedGoogle Scholar
  36. 36.
    Shepherd, J., A.M. Gotto, Jr., O.D. Taunton, M.J. Caslake, and E. Farish, Biochim. Biophys. Acta 489:486 (1977).PubMedGoogle Scholar
  37. 37.
    Eisenberg, S., T. Chajek, and R. Deckelbaum, J. Am. Oil Chem. Soc. 55:256 (1978) (Abstract).Google Scholar
  38. 38.
    Fainaru, M., M.C. Glangeaud, and S. Eisenberg, Biochim. Biophys. Acta 386:432 (1975).PubMedGoogle Scholar

Copyright information

© American Oil Chemists’ Society 1978

Authors and Affiliations

  • Gustav Schonfeld
    • 1
  • Alberta Bailey
    • 1
  • Robert Steelman
    • 1
  1. 1.Lipid Research Center, Department of Preventive Medicine and MedicineWashington University School of MedicineSt. Louis

Personalised recommendations